CAJ | 학술논문

技术创新不足已经成为阻碍中药产业进一步发展的主要障碍。对163个样本中药企业进行回归分析，结果表明，中药企业规模与技术创新的关系呈倒 U 型，并且我国中药企业的规模多处于倒 U 的左侧。中药产业处于规模驱动发展期，因此突破规模约束有利于促进中药企业技术创新。通过企业兼并提高中药企业规模，增强中药企业的内涵建设，加大政府对中小中药企业的支持力度，注重建立地区中药产业生态集群是突破中药企业规模约束的重要途径。
기술창신불족이경성위조애중약산업진일보발전적주요장애。대163개양본중약기업진행회귀분석，결과표명，중약기업규모여기술창신적관계정도 U 형，병차아국중약기업적규모다처우도 U 적좌측。중약산업처우규모구동발전기，인차돌파규모약속유리우촉진중약기업기술창신。통과기업겸병제고중약기업규모，증강중약기업적내함건설，가대정부대중소중약기업적지지력도，주중건입지구중약산업생태집군시돌파중약기업규모약속적중요도경。
Lack of technological innovation has become a crucial obstacle to the further development of traditional Chinese medicine industry.According to the regression analysis of 163 samples of Chinese medicine companies,the results showed that the relationship between medicine enterprise scale and technology innovation is inverted-U-shaped,and that most of Chinese medicine enterprises'scale are located in the left side of the U,indicating Chinese medicine industry is in the period of scale-driven development.Therefore,breaking the constraints of scale will be good for the technological innovation.The following are crucial ways,including corporate mergers,enhancing the connotation construction of TCM companies,increasing the government support to the small and medium scale of enterprises,focusing on establishing Chinese medicine industry ecosystem clusters.